YSG combines strong digital-native capabilities with a diversified beauty brand portfolio that spans mass and premium segments. It has materially improved its cost structure, strengthened gross margins, and narrowed operating losses, suggesting better operational discipline. The balance sheet remains lightly leveraged with low financial debt and still-adequate liquidity, providing some breathing room. Its growing R&D platform, proprietary technologies, and emphasis on skincare and functional beauty position it for structurally higher-margin categories over time.

Key risks center on sustained unprofitability, negative free cash flow, and a steadily shrinking cash and asset base. Deeply negative retained earnings and declining equity reflect years of losses and asset write-downs, which reduce financial resilience. Competitive intensity in China’s beauty market, fast-changing consumer trends, and regulatory or platform-related shifts could all disrupt growth plans. Continued share repurchases in the face of cash burn also raise questions about capital allocation priorities if operating performance does not improve more decisively.

YSG appears to be in the middle innings of a strategic transition: from high-growth, marketing-heavy color cosmetics to a more balanced, science-led portfolio with greater emphasis on skincare and profitability. The direction of change in margins and cost efficiency is encouraging, but the company has not yet translated this into consistent profits or positive cash flow. Near-term, the focus is likely to remain on stabilizing revenue, further optimizing costs, and carefully pacing investment to preserve liquidity. Longer term, the outlook will hinge on whether its R&D-driven, multi-brand strategy can deliver enough scale and pricing power to turn the improving trends into a durable, self-funding business model.